Qualitative and quantitative differences in the cellular responses mediated through Fas antigen and tumor necrosis factor receptor

Journal of Interferon and Cytokine Research

Volumn 16, Issue 3, 1996, Pages 259-267

  Totpal, Klara ^a   Singh, Sanjaya ^a   Lapushin, Ruth ^a   Aggarwal, Bharat B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CELL MEDIATED CYTOTOXICITY; CELL PROLIFERATION; CELLULAR IMMUNITY; DNA DEGRADATION; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029931007     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1996.16.259     Document Type: Article

References (47)

1. AGGARWAL, B.B., and VILCEK, J. (eds.) (1992). Tumor Necrosis Factor: Structure, Function, and Mechanism of Action. New York: Marcel Dekker.
2. GOEDDEL, D.V., AGGARWAL, B.B., GRAY, P.W., LEUNG, D.W., NEDWIN, G.E., PALLADINO, M.A., PATTON, J.S., PENNICA, D., SHEPARD, H.M., SUGARMAN, B.J., and WONG, G.H.W. (1986). Tumor necrosis factors: gene structure and biological activities. Cold Spring Harbor Symp. Quant. Biol. 51, 597-609.
3. LOETSCHER, H., PAN, Y.-C.E., LAHM, H.-W., GENTZ, R., BROCKHAUS, M., TABUCHI, H., and LESSLAUER, W. (1990). Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 61, 351-359.
4. SCHALL, T.J., LEWIS, M., KOLLER, K.J., LEE, A., RICE, G.C., WONG, G.H.W., GATANAGA, T., GRANGER, G.A., LENTZ, R., RAAB, H., KOHR, W.J., and GOEDDEL, D.V. (1990). Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61, 361-370.
5. SMITH, C.A., DAVIS, T., ANDERSON, D., SOLAM, L., BECKMAN, M.P., JERZY, R., DOWER, S.K., COSMAN, D., and GOODWIN, R.G. (1990). A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248, 1019-1023.
6. KOHNO, T., BREWER, M.T., BAKER, S.L., SCHWALTZ, P.E., KING, M.W., HALE, K.K., SQUIRES, C.H., THOMPSON, R.C., and VANNICE, J.L. (1990). Second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc. Natl. Acad. Sci. USA 87, 8331-8335.
7. DEMBIC, Z., LOETSCHER, H., GUBLER, U., PAN, Y.-C.E., LAHM, H.-W., GENTZ, R., BROCKHAUS, M., and LASSLAUER, W. (1990). Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. Cytokine 2, 231-237.
8. BROCKHAUS, M., SCOENFELD, H.-J., SCHLAEGER, E.-J., HUNZIKER, W., LESSLAUER, W., and LOETSCHER, H. (1990). Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc. Natl. Acad. Sci. USA 87, 3127-3131.
9. HOHMANN, H.-P., REMY, R., BROCKHAUSE, M., and VANLOON, A.P.G.M. (1989). Two different cell types have different major receptors for human tumor necrosis factor (TNFα). J. Biol. Chem. 264, 14927-14934.
10. HOHMANN, H.-P., BRACKHAUS, M., BAEUERLE, P.A., REMY, R., KOLBECK, R., and VAN LOON, A.P.G.M. (1990). Expression of the types A and B tumor necrosis factor (TNF) receptor is independently regulated, and both receptors mediate activation of the transcription factor NF-κ. J. Biol. Chem. 265, 22409-22417.
11. AGGARWAL, B.B., GRAFF, K., SAMAL, B., HIGUCHI, M., and LIAO, W. (1993). Regulation of two forms of the TNF receptors by phorbol ester and dibutyryl cyclic adenosine 3′,5′-monophosphate in human histiocytic lymphoma cell line U-937. Lymphokine Cytokine Res. 12, 149-158.
12. ERIKSTEIN, B.K., SMELAND, E.B., BLOMHOFF, H.K., FUNDERUD, S., PRYDZ, K., LESSLAUER, W., and ESPEVIK, T. (1991). Independent regulation of 55-kDa and 75-kDa tumor necrosis factor receptors during activation of human peripheral blood B lymphocytes. Eur. J. Immunol. 21, 1033-1037.
13. THOMA, B., GRELL, M., PFIZENMAIER, K., and SCHEURICH, P. (1990). Identification of 60-kD tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses. J. Exp. Med. 172, 1019-1023.
14. TARTAGLIA, L.A., WEBER, R.F., FIGARI, I.S., REYNOLD, C., PALLADINO, M.A., Jr, and GOEDDEL, D.V. (1991). The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. USA 88, 9292-9296.
15. WONG, G.H.W., TARTAGLIA, L.A., LEE, M.S., and GOEDDEL, D.V. (1992). Antiviral activity of tumor necrosis factor (TNF) is signaled through the 55-kDa receptor, type I TNF. J. Immunol. 149, 3350-3353.
16. GRELL, M., SCHEURICH, P., MEAGER, A., and PFIZENMAIER, K. (1993). TR60 and TR80 tumor necrosis factor (TNF)-receptors can independently mediate cytolysis. Lympohokine Cytokine Res. 12, 143-148.
17. HELLER, R.A., SONG, K., FAN, N., and CHANG, D.J. (1992). The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell 70, 47-56.
18. HIGUCHI, M., and AGGARWAL, B.B. (1993). P80 form of the human tumor necrosis factor receptor is involved in DNA fragmentation. FEBS Lett. 331, 252-255.
19. HIGUCHI, M., and AGGARWAL, B.B. (1992). Modulation of two forms of tumor necrosis factor receptors and their cellular response by soluble receptors and their monoclonal antibodies. J. Biol. Chem. 267, 20892-20899.
20. HIGUCHI, M., and AGGARWAL, B.B. (1994). Differential roles of two types of the TNF receptor in TNF-induced cytotoxicity, DNA fragmentation and differentiation. J. Immunol. 152(8), 4017-4025.
21. HIGUCHI, M., and AGGARWAL, B.B. (1994). Tumor necrosis factor induces internalization of the p60 receptor and shedding of the p80 receptor. J. Immunol. 152(7), 3550-3558.
22. DARNAY, B.G., REDDY, S.A.G., and AGGARWAL, B.B. (1994). Physical and functional association of a serine-threonine protein kinase to the cytoplasmic domain of the p80 form of the human tumor necrosis factor receptor in human histiocytic lymphoma U-937 cells. J. Biol. Chem. 269, 19687-19690.
23. VANDENABEELE, P., DECLERCQ, W., VANHAESEBROECK, B., GROOTEN, J., and FIERS, W. (1995). Both TNF receptors are required for TNF-mediated induction of apoptosis in PC60 cells. J. Immunol. 154, 2904-2913.
24. YONEHARA, S., ISHI, A., and YONEHARA, M. (1989). A cell killing monoclonal antibody (anti Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169, 1747-1756.
25. TRAUTH, B.C., KLAS, C., PETERS, M.A.J., MATZKU, S., MOLLER, P., FALK, W., DEBATIN, K.M., and KRAMMER, P.H. (1989). Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245, 301-305.
26. ITOH, N., YONEHARA, S., ISHII, A., YONEHARA, M., MIZUSHIMA, S.I., SAMESHIMA, M., HASE, A., SETO, Y., and NAGATA, S. (1991). The polypeptide encoded by the cDNA far human cell surface antigen Fas can mediate apoptosis. Cell 66, 233-243.
27. SUDA, T., TAKAHASHI, T., GOLSTEIN, P., and NAGATA, S. (1993). Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75, 1169-1178.
28. WATANABE-FUKUNAGA, R., BRANNAN, C.I., ITOH, N., YONEHARA, S., COPELAND, N.G., JENKINS, N.A., and NAGATA, S. (1992). The cDNA structure, expression and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148, 1274-1279.
29. TARTAGLIA, L.A., AYRES, T.M., WONG, G.H.W., and GOEDDEL, P.V. (1993). A novel domain within the 55 kd TNF receptor signals cell death. Cell 74, 845-853.
30. ITOH, N., and NAGATA, S. (1993). A novel protein domin required for apoptosis: mutational analysis of human Fas antigen. J. Biol. Chem. 268, 10932-10937.
31. AGGARWAL, B.B., SINGH, S., LAPUSHIN, R., and TOTPAL, K. (1995). Fas antigen signals proliferation of normal human diploid fibroblast and its mechanism is different from tumor necrosis factor receptor. FEBS Lett. 364, 5-8.
32. SCHREIBER, E., MATTHIAS, P., MULLER, M.M., and SCHAFFNER, W. (1989). Rapid detection of octamer binding proteins with "mini-extracts", prepared from a small number of cells. Nucleic Acids Res. 17, 6419.
33. BRADFORD, M.M. (1976). A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
34. NABEL, G., and BALTIMORE, D. (1987). An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326, 711-713.
35. COLLART, M.A., BAEUERLE, P., and VASSALLI, P. (1990). Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB. Mol. Cell. Biol. 10, 1498-1506.
36. HASSANAIN, H.H., DAI, W., and GUPTA, S.L. (1993). Enhanced gel mobility shift assay for DNA-binding factors. Anal. Biochem. 213, 162-167.
37. SINGH, H., LEBOWITZ, J.H., BALDWIN, A.S., Jr., and SHARP, P.A. (1988). Molecular cloning of an enhancer binding protein: isolation by screening of an expression library with a recognition site DNA. Cell 52, 415-123.
38. LASTER, S.M., WOOD, J.G., and GOODING, L.R. (1988). Tumor necrosis factor can induce both apoptotic and necrotic forms of cell lysis. J. Immunol. 141, 2629-2634.
39. WONG, G.H.W., and GOEDDEL, D.V. (1994). Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways. J. Immunol. 152, 1751-1755.
40. CLEMENT, M.-V., and STAMENKOVIC, I. (1994). Fas and tumor necrosis factor receptor-mediated cell death: similarities and disctinctions. J. Exp. Med. 180, 557-567.
41. SCHULZE-OSTHOFF, K., KRAMMER, P.H., and DROGE, W. (1994). Divergent signalling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO J. 13, 4587-1596.
42. GRELL, M., KRAMMER, P.H., and SCHEURICH, P. (1994). Segregation of APO-1/Fas antigen and tumor necrosis factor receptor-mediated apoptosis. Eur. J. Immunol. 24, 2563-2566.
43. LIBERMANN, T.A., and BALTIMORE, D. (1990). Activation of Interleukin-6 gene expression through the NF-κB transcription factor. Mol. Cell. Biol. 10, 2327-2334.
44. KOBAYASHI, N., HAMAMOTO, Y., YAMAMOTO, N., ISHII, A., and YONEHARA, M. (1990). Anti-fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Proc. Natl. Acad. Sci. USA 87, 9620-9624.
45. CHATURVEDI, M., HIGUCHI, M., and AGGARWAL, B.B. (1994). Effect of tumor necrosis factors, interferons, interleukins and growth factors on the activation of NF-κB: evidence for lack of synergism between cytokines and for lack of correlation with cytotoxicity. Lymphokine Cytokine Res. 13, 309-314.
46. ITOH, N., TSUJIMOTO, Y., and NAGATA, S. (1993). Effect of bcl-2 on Fas antigenmediated cell death. J. Immunol. 151, 621-627.
47. YOSHINO, T., KONDO, E., CAO, L., TAKAHASHI, K., HAYASHI, K., NOMURA, S., and AKAGI, T. (1994). Inverse expression of bcl-2 protein and fas antigen in lymphoblasts in peripheral lymph nodes and activated peripheral blood T and B lymphocytes. Blood 83(7), 1856-1861.